Mavacamten-like myosin inhibitor MYK-581 reduces the risk of atrial fibrillation induction in a murine model of hypertrophic cardiomyopathy

Heart Rhythm 2026

View at publisher

Authors: Jeffrey Schmeckpeper, Kyungsoo Kim, Amanda Berge, Pallav Bulsara, Björn C. Knollmann

DOI: 10.1016/j.hrthm.2026.02.012

Cited by: 0

References: 3

Fields of Study & Subjects

Cardiomyopathy and Myosin Studies Cardiac electrophysiology and arrhythmias Atrial Fibrillation Management and Outcomes

References 3